ATOSSA THERAPEUTICS INC (ATOS) Institutional Ownership
None of the superinvestors we track currently report ATOSSA THERAPEUTICS INC (ATOS) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in ATOSSA THERAPEUTICS INC (ATOS), this page will show institutional position trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q4 2025 | 1 | $1,217,074 | 2,062,838 |
| Q3 2025 | 1 | $1,342,691 | 1,548,663 |
| Q2 2025 | 1 | $1,504,168 | 1,812,251 |
| Q1 2025 | 1 | $1,248,297 | 1,855,101 |
| Q4 2024 | 1 | $1,470,560 | 1,557,632 |
| Q3 2024 | 1 | $1,991,306 | 1,310,070 |
| Q2 2024 | 1 | $1,845,583 | 1,550,910 |
| Q1 2024 | 1 | $2,495 | 1,386,370 |
| Q4 2023 | 1 | $1,130 | 1,284,270 |
| Q3 2023 | 1 | $915 | 1,242,370 |
| Q2 2023 | 1 | $1,353 | 1,074,070 |
| Q1 2023 | 1 | $679 | 936,070 |
Related ATOS Institutional Insights:
- ATOS Institutional Ownership & Insiders Activity
- ATOS Institutional Ownership & 13F Activity
- ATOS Top Institutional Shareholders
- ATOS Institutional Buying Activity
- ATOS Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- ATOS Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings